17 0.33 (1.98%) | 09-13 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 22.12 | 1-year : | 23.95 |
Resists | First : | 18.93 | Second : | 20.51 |
Pivot price | 18.07 | |||
Supports | First : | 16.39 | Second : | 13.64 |
MAs | MA(5) : | 16.86 | MA(20) : | 18.23 |
MA(100) : | 19.2 | MA(250) : | 18.66 | |
MACD | MACD : | -1 | Signal : | -0.9 |
%K %D | K(14,3) : | 8.4 | D(3) : | 7.5 |
RSI | RSI(14): 32.6 | |||
52-week | High : | 25.2 | Low : | 13.81 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CLB ] has closed above bottom band by 22.7%. Bollinger Bands are 21.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 17.34 - 17.42 | 17.42 - 17.5 |
Low: | 16.64 - 16.73 | 16.73 - 16.82 |
Close: | 16.84 - 17 | 17 - 17.14 |
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Mon, 02 Sep 2024
Here's Why Core Laboratories (CLB) is a Strong Value Stock - Yahoo Finance
Fri, 23 Aug 2024
Core Laboratories (CLB) Down 25.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Thu, 25 Jul 2024
Earnings call: Core Laboratories reported a reduction in net debt - Investing.com
Tue, 30 Apr 2024
Core Laboratories N.V. (NYSE:CLB) Q1 2024 Earnings Call Transcript - Yahoo Finance
Mon, 09 Oct 2023
CORE LABORATORIES AND HALLIBURTON ANNOUNCE COLLABORATION TO INTEGRATE DIGITAL ROCK CAPABILITIES WITH LABORATORY MEASURED DATA - PR Newswire
Tue, 17 Jan 2023
CORE LAB ANNOUNCES PROPOSED REDOMESTICATION TO THE UNITED STATES - PR Newswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NYSE
|
|
Sector:
Energy
|
|
Industry:
Oil & Gas Equipment & Services
|
|
Shares Out | 47 (M) |
Shares Float | 46 (M) |
Held by Insiders | 0.8 (%) |
Held by Institutions | 113 (%) |
Shares Short | 7,930 (K) |
Shares Short P.Month | 7,320 (K) |
EPS | 0.5 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 5.11 |
Profit Margin | 4.6 % |
Operating Margin | 11.3 % |
Return on Assets (ttm) | 5.7 % |
Return on Equity (ttm) | 10.4 % |
Qtrly Rev. Growth | 2 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 10.95 |
EBITDA (p.s.) | 1.5 |
Qtrly Earnings Growth | -60.5 % |
Operating Cash Flow | 42 (M) |
Levered Free Cash Flow | 33 (M) |
PE Ratio | 34 |
PEG Ratio | 1 |
Price to Book value | 3.32 |
Price to Sales | 1.55 |
Price to Cash Flow | 19.03 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |